Search - tctmd.com

Displaying 541 - 560 of 667

Sort: Relevancy | Date

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

July 17, 2014

News Daily News

Subestudio ACUITY: La Puntuación obtenida en la Escala Syntax Guarda Relación con la Trombosis del Stent en Pacientes SCASEST

L.A. McKeown

July 09, 2014

News Daily News

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

L.A. McKeown

July 09, 2014

News Daily News

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

L.A. McKeown

June 27, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Daily News

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

Yael L. Maxwell

April 24, 2014

News Daily News

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

L.A. McKeown

April 18, 2014

News Daily News

Patients with Cardiac Arrest Fare Poorly After PCI

April 17, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

April 09, 2014

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

News Daily News

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

L.A. McKeown

April 03, 2014

News Daily News

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

L.A. McKeown

April 03, 2014

News Conference News ACC 2014

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Jason Kahn

March 31, 2014

Advertisement

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

Subestudio ACUITY: La Puntuación obtenida en la Escala Syntax Guarda Relación con la Trombosis del Stent en Pacientes SCASEST

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

Study of STEMI Care in China Exposes Crucial Treatment Gaps

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

Patients with Cardiac Arrest Fare Poorly After PCI

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content